11,15 Dimethyl-11 deoxy PGF{HD 2 {B
    1.
    发明授权
    11,15 Dimethyl-11 deoxy PGF{HD 2 {B 失效
    11,15二甲基-11脱氧PGF {HD 2 {

    公开(公告)号:US3919302A

    公开(公告)日:1975-11-11

    申请号:US44683574

    申请日:1974-02-28

    CPC classification number: C07C405/00

    Abstract: The topical application of 7-(5 Alpha -hydroxy-2 Beta -((3RS)-3hydroxy-3-methyl-trans-1-octenyl)-3 Alpha -methyl-1 Alpha cyclopentyl)-cis-6-heptenoic acid, 7-(5 Alpha -hydroxy-2 Beta ((3RS)-3-hydroxy-3-methyl-trans-1-octenyl)-1 Alpha -cyclopentyl)cis-5-heptenoic acid, or 7-(2 Beta -((3RS)-hydroxy-3-methyltrans-1-octenyl)-5-oxo-1 Alpha -cyclopentyl)-cis-5-heptenoic acid to a wound surface can be employed to attenuate bleeding. The compounds are prepared from the prostaglandin PGA2.

    Abstract translation: 7-(5α-羟基-2β - [(3RS)-3-羟基-3-甲基 - 反-1-辛烯基]-3α-甲基-1α-环戊基) - 顺式-6- 庚烯酸,7-(5α-羟基-2β - [(3RS)-3-羟基-3-甲基 - 反-1-辛烯基]-1α-环戊基) - 顺式-5-庚烯酸或7- (2β-[(3RS) - 羟基-3-甲基 - 反-1-辛烯基] -5-氧代-1α-环戊基) - 顺式-5-庚烯酸可以用于减少出血。 该化合物由前列腺素PGA2制备。

Patent Agency Ranking